Vikash Kumar Jain from CLSA discusses India’s bullish market trends, potential for low returns, and the recent growth in the pharma sector. He highlights the need not to view global sectors through the India lens and says that will be a blatant mistake. Jain expects increased investment flows into India only after there is rising confidence in emerging markets.
Sebi board meeting: Regulator eases IPO rules for start-up founders, mandates dematerialisation of securities
SEBI has relaxed ESOP rules for startup founders, allowing them to retain or exercise share-based benefits post-listing, provided they received them at least a year
June 18, 2025